Silence Therapeutics
SLN
Silence Therapeutics (SLN) earnings history
Most recent quarter
- Fiscal period
- Q3 2025
- Period end
- Sep 30, 2025
- EPS actual
- −$0.15
- EPS estimate
- −$0.19
- EPS surprise
- +19.83%
- Revenue surprise
- −96.37%
- Revenue
- $159,000.00
- Revenue estimate
- $4.4M
- Reported
- Nov 6, 2025
Earnings history
| Period | Reported | EPS estimate | EPS actual | Surprise | Revenue | Filing |
|---|---|---|---|---|---|---|
| Q3 2025 | Nov 6, 2025 | −$0.19 | −$0.15 | +19.83% | $159,000.00 | SEC |
| Q2 2025 | Aug 7, 2025 | −$0.13 | −$0.19 | −43.40% | $224,000.00 | SEC |
| Q1 2025 | May 8, 2025 | −$0.15 | −$0.20 | −32.63% | $142,000.00 | SEC |
| Q3 2024 | Nov 14, 2024 | −$0.13 | −$0.24 | −90.35% | $1.5M | SEC |
| Q2 2024 | Aug 15, 2024 | −$0.11 | −$0.14 | −25.18% | $768,579.00 | SEC |
| Q1 2024 | May 16, 2024 | −$0.12 | −$0.02 | +85.29% | $15.7M | SEC |
| Q4 2023 | Mar 13, 2024 | −$0.08 | −$0.16 | −98.38% | $2.7M | SEC |
| Q3 2023 | Nov 14, 2023 | −$0.17 | −$0.09 | +46.36% | $3.5M | SEC |
| Q2 2023 | Aug 16, 2023 | −$0.17 | −$0.12 | +29.21% | $11.6M | SEC |
| Q1 2023 | May 16, 2023 | −$0.15 | −$0.12 | +21.28% | $14.2M | SEC |
| Q4 2022 | Mar 15, 2023 | −$0.01 | $0.45 | +3748.39% | $17.8M | SEC |
| Q3 2022 | Nov 10, 2022 | −$0.20 | −$0.08 | +58.18% | $3.9M | — |
| Q2 2022 | Aug 11, 2022 | −$0.20 | −$0.16 | +19.84% | $4.3M | — |
| Q1 2022 | May 16, 2022 | −$0.19 | −$0.11 | +44.76% | $7.0M | — |
Quarterly revenue
Frequently asked questions
When did Silence Therapeutics (SLN) last report earnings?
Silence Therapeutics last reported on Nov 6, 2025, covering fiscal Q3 2025.
Did SLN beat earnings estimates?
Yes. Silence Therapeutics reported EPS of −$0.15 for Q3 2025 against a −$0.19 estimate — a 19.83% beat.
How much revenue did SLN report last quarter?
Silence Therapeutics reported $159,000.00 in revenue for Q3 2025, against a consensus estimate of $4.4M.
Earnings figures may be restated, revised or corrected by the issuer. Past results do not indicate future performance.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.